Clinical Scorecard: Fibroblast Signals Shape Renal Fibrosis
At a Glance
| Category | Detail |
|---|---|
| Condition | Renal Fibrosis |
| Key Mechanisms | Fibroblast-derived neuropilin 1 (NRP1) influences fibroblast activation and myofibroblast transdifferentiation. |
| Target Population | Patients with chronic kidney disease. |
| Care Setting | Experimental pathology and disease modeling. |
Key Highlights
- Fibroblast NRP1 deletion leads to more severe interstitial fibrosis in kidney injury models.
- Increased collagen deposition and myofibroblast expansion observed in NRP1-deficient kidneys.
- Fibroblast activation is heterogeneous, affecting fibrosis severity independently of injury type.
- NRP1 supports a reparative fibroblast state, limiting maladaptive fibrosis progression.
- Single-cell RNA sequencing data shows NRP1 enrichment in fibroblasts linked to inflammation and healing.
Guideline-Based Recommendations
Diagnosis
- Further research needed to establish diagnostic applications for NRP1.
Management
- Understanding fibroblast signaling may inform future therapeutic strategies.
Monitoring & Follow-up
- Markers like NRP1 could refine interpretation of fibroblast populations in tissue analysis.
Risks
- Increased fibrosis severity may occur in absence of NRP1 during chronic kidney injury.
Patient & Prescribing Data
Individuals with chronic kidney disease exhibiting renal fibrosis.
Potential for future biomarker development based on fibroblast signaling mechanisms.
Clinical Best Practices
- Consider fibroblast heterogeneity in assessing fibrosis severity.
- Utilize NRP1 as a potential marker in immunostaining and single-cell analyses.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
